Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evidence of Autologous Platelet-Rich Plasma as a Treatment for Macular Holes

NCT06323902 is registered in ClinicalTrials.gov with Clinica Oftalmologica Paredes as lead sponsor.

NCT NCT06323902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06323902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evidence of Autologous Platelet-Rich Plasma as a Treatment for Macular Holes
Lead sponsor
Clinica Oftalmologica Paredes
Phase
Observational
Overall status
Completed
Start date
October 25, 2022
Completion date
February 29, 2024
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular hole of left eye (disorder), macular hole of right eye (disorder), macular holes